By Stephen Nakrosis
EXoZymes and MDB Capital Holdings said Mo Hayat has transitioned out of his roles as chairman and president. Christopher Marlett, MDB's chief executive, will become chairman.
Marlett will ensure MDB will continue to provide help and support for eXoZymes, the company said Friday. Hayat will focus on new MDB Capital ventures.
Edgardo Rayo will also join the board on behalf of MDB Capital, according to eXoZymes.
The transition follows eXoZymes' corporate rebranding from Invizyne Technologies, which took place earlier this month. Shares trade on the Nasdaq under the symbol EXOZ.
Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
February 21, 2025 16:47 ET (21:47 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.